U.S. Infrastructure Stock News

Samsara (IOT) just rolled out its Fuel Command Center, a product that centralizes fuel spend data, routing choices, and card controls for commercial fleets facing sharp fuel price swings and growing misuse risks. Samsara’s new Fuel Command Center arrives after a year where momentum has been building, with a 30 day share price return of 10.44%, a year to date share price return of 21.34%, and a 3 year total shareholder return of 33.07%. Scan for other fuel and fleet efficiency plays moving on...

Xylem Inc. recently announced that Andrea van der Berg has taken over as Chief Financial Officer and Executive Vice President, succeeding William “Bill” Grogan, who stayed through mid‑September 2026 to support the transition. This move elevates an internal leader with deep experience across finance, operations, and water infrastructure, potentially influencing how Xylem manages capital, integration efforts, and long-range financial planning. We’ll now assess how elevating internal finance...

In recent days, reports indicated that Chevron has been close to signing multi-billion-dollar agreements to expand its Venezuelan operations by adding two heavy-oil fields under its existing US license, deepening its role in rebuilding the country’s sanctioned oil sector. This push into Venezuela, alongside U.S. government efforts to secure long-term access to the nation’s crude reserves, highlights how Chevron is tying its heavy-oil portfolio to complex geopolitics and policy...

Nutanix stock has delivered a strong 3 year return while the valuation checks send mixed messages. The Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading below that model’s fair value, while market based multiples suggest the stock is priced on the richer side. Nutanix has returned 98.2% over the past 3 years, which puts more weight on whether the current valuation still leaves enough room for further gains. New AI focused offerings and partnerships around...

CrowdStrike Holdings recently reported past second-quarter 2026 results showing revenue of US$1,470.9 million and net income of US$5.31 million, while also issuing higher full-year and third-quarter revenue guidance that now targets up to US$6.01 billion for the year ending January 31, 2027. Management linked this performance and outlook upgrade to rising demand for its AI-focused cybersecurity platform, as enterprises respond to expanding AI-driven threat exposure and increasingly...

Sea stock presents a split picture for investors. A Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading at a steep discount, while earnings based multiples suggest the stock is already pricing in a lot of optimism. Sea has delivered a 3 year return of 209.9%, which puts the current share price in the context of a long period of strong gains despite more recent weakness. Expectations around Sea's ability to turn its business mix into durable cash generation can...

Earlier this month, Kratos Defense & Security Solutions and GE Aerospace announced that their GEK800 turbofan engine, now designated the F143-ZZ-100, secured a U.S. Air Force Engineering, Manufacturing and Development contract as a second-source propulsion system for the Joint Air-to-Surface Standoff Missile after completing extensive ground and altitude testing. This contract underscores GE Aerospace’s expanding role in supplying small, high-performance engines for cruise missiles and...

Ouster (OUST) is back in focus after GUSS Automation announced plans to integrate the company’s Rev8 OS0 native color digital lidar sensors into its next generation autonomous orchard machine fleet. The GUSS integration news lands after a volatile stretch for Ouster, with the share price down 5.25% over the last day and 22.95% over the past 90 days. The stock still shows a 48.14% year to date share price return and a 1 year total shareholder return of 21.35% as part of a very large 3 year...

Why NetScout Systems Stock Is Back On Investor Radar NetScout Systems (NTCT) has rolled out updates to its Arbor Edge Defense and Adaptive DDoS Protection products, targeting sophisticated attacks that slip past content delivery networks and originate from compromised devices. These product moves put the focus on how NetScout Systems is positioned in carrier service assurance and cybersecurity. They also give investors fresh information to weigh against the stock’s recent price performance...

Guidance raise puts Fortinet stock in focus Fortinet (FTNT) is back on investors’ radar after the company raised its full-year 2026 revenue guidance and improved its non GAAP EPS outlook, a move that has influenced recent market sentiment. Fortinet’s share price has been volatile in the short term, with the stock down 3.9% over the last day but up 8.1% over the past week and 12.8% over the past 90 days. The year-to-date share price return of 113.2% and 1-year total shareholder return of...

Amentum Holdings (AMTM) stock is in focus after a series of new contract wins, including a US$974 million Center Maintenance, Operations, and Engineering II award at NASA’s Langley Research Center. Despite these contract wins across space, defence, and nuclear infrastructure, Amentum Holdings’ recent share price return has been weak. The stock is down 5.49% over the past week and 8.51% over the past month, while the year-to-date share price return of 33.37% and 1 year total shareholder return...

Arm Holdings plc previously presented at the 5th TestMu Conference on August 19, 2026, where Head of Developer Relations Prashant Sharma highlighted the company’s engagement with the software testing and developer community. This focus on developer relations underscores how Arm’s broad ecosystem support remains a key ingredient in extending its architecture across AI and other compute markets. Next, we’ll examine how sector-wide chipmaker weakness and macro uncertainty surrounding...

Baldwin Insurance Group (BWIN) is back in focus after fresh commentary highlighted several financial pressure points. Rising costs versus revenue, a weaker free cash flow margin, and a high net-debt-to-EBITDA ratio are now front and center for investors. The share price of Baldwin Insurance Group has had a strong run over the past quarter, with a 90 day share price return of 51.96% and a 30 day share price return of 10.60%, even though the 1 year total shareholder return is down 3.13%. At the...

China Yuchai International stock has delivered a very strong multi year return, yet current valuation checks still flag it as looking cheap on several fronts. After the recent pullback, the question for investors is how to weigh that longer term performance against the latest value signals. China Yuchai International has returned about 272% over the past 3 years, which puts its recent slide in a very different light compared with its longer term track record. Future demand for its engines...

Figma stock performance snapshot Figma (FIG) has drawn investor attention after recent trading left the stock closing at US$28.82, with the price move over the past month and past 3 months contrasting with a weaker return over the past year. The recent 1 month share price return of 16.4% and 3 month share price return of 13.0% suggest improving momentum for Figma, even though the year to date share price return is down 23.4% and the 1 year total shareholder return has declined 59.0%. Compare...

In recent days, Mastercard’s re-entry into Syria through QNB Group enabled the first international Mastercard transaction there in more than 15 years, while a new partnership with Klook aims to enrich Asia Pacific travel experiences through exclusive cardholder benefits and tailored payment solutions. At the same time, large new positions in Mastercard by Pershing Square and Bill Ackman, alongside moves into stablecoin infrastructure and machine-to-machine payments, highlight how investors...

National HealthCare (NHC) has drawn fresh attention after its recent share performance, with the stock around $222.70 and a reported intrinsic discount of about 49%, putting its valuation in focus for healthcare investors. Over the past year, National HealthCare has combined a sharp year-to-date share price return of 70.77% with a 1-year total shareholder return of 99.63%. This points to strong momentum despite a recent 7-day share price pullback of 4.58% and a softer 1-month share price...

Pool (POOL) has drawn investor attention after its shares closed at $188.07, with returns over the past month and past 3 months differing from its weaker year to date and 1 year performance. Readers are reassessing expectations around the business and valuation. For Pool, the recent 1 day share price return of 1.08% and 90 day share price return of 3.30% sit against a weaker picture. Total shareholder returns have declined over 1, 3 and 5 years, which suggests short term momentum is modest...

With the July JOLTS report and August jobs data about to test the strength of the U.S. labor market, interest rate expectations and growth stock sentiment could shift quickly. That mix of softer hiring signals, stubborn inflation and higher financing costs creates potential mispricing in interest rate sensitive growth stocks. This article walks through three stocks from our screener that look especially exposed to these cross currents. The three stocks below are just a starting sample. The...

What recent performance says about Independence Realty Trust stock Independence Realty Trust (IRT) has drawn investor attention after its shares closed at US$16.31, with the stock down over the past month but slightly higher across the past 3 months. For investors tracking consistency, the stock shows declines over the past week and year to date, alongside a fall over the past year on a total return basis, yet a gain across the past 3 years. Stepping back, Independence Realty Trust’s recent...

On 24 August 2026, Johnson & Johnson received U.S. FDA approval for IMAAVY (nipocalimab-aahu) to treat warm autoimmune hemolytic anemia in patients aged 12 and older who are currently or were previously treated with corticosteroids. This decision makes IMAAVY the first approved therapy for this rare, life‑threatening condition in steroid-treated patients, highlighting Johnson & Johnson’s push into targeted autoimmune treatments that spare broad immune suppression. We’ll now examine how...

Celcuity (NasdaqCM: CELC) has submitted a supplemental New Drug Application to the FDA for REVTORPYK to treat advanced breast cancer patients with PIK3CA mutations. The filing is backed by Phase 3 VIKTORIA-1 trial results that showed significantly improved progression free survival in this patient group. If approved, REVTORPYK could become the first and only therapy specifically for this indication, which would expand Celcuity's potential market exposure. This kind of targeted oncology...

Cisco Systems recently expanded its Secure AI Factory with NVIDIA through a partnership with Super Micro Computer, adding Super Micro’s high-density liquid- and air-cooled compute systems to Cisco’s full-stack AI infrastructure for enterprises, neoclouds, and sovereign clouds. This move makes Super Micro a core hardware supplier within Cisco’s AI ecosystem, potentially broadening its reach into complex, large-scale AI deployments that blend dense GPU clusters with traditional workloads and...

National Fuel Gas stock is coming off a strong five year run, yet current valuation checks send mixed messages about how much upside may still be on the table. The intrinsic value estimate using a Discounted Cash Flow (DCF) approach points to a share price that is very close to current trading levels, while market based multiples suggest the stock may be on the cheap side. Over the past 5 years, National Fuel Gas has returned 84.6%, which puts more pressure on today’s entry price to be well...